Dana Investment Advisors Inc. Sells 88,725 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Dana Investment Advisors Inc. cut its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 9.7% during the 4th quarter, Holdings Channel reports. The firm owned 826,830 shares of the company’s stock after selling 88,725 shares during the period. Dana Investment Advisors Inc.’s holdings in Pediatrix Medical Group were worth $10,848,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Proficio Capital Partners LLC bought a new position in shares of Pediatrix Medical Group during the fourth quarter worth approximately $404,000. M&T Bank Corp increased its stake in Pediatrix Medical Group by 16.2% in the fourth quarter. M&T Bank Corp now owns 99,090 shares of the company’s stock valued at $1,300,000 after acquiring an additional 13,826 shares during the last quarter. Victory Capital Management Inc. increased its stake in Pediatrix Medical Group by 95.8% in the fourth quarter. Victory Capital Management Inc. now owns 76,553 shares of the company’s stock valued at $1,004,000 after acquiring an additional 37,463 shares during the last quarter. Bailard Inc. bought a new position in Pediatrix Medical Group in the fourth quarter valued at approximately $161,000. Finally, Smartleaf Asset Management LLC increased its stake in Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after acquiring an additional 6,090 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. UBS Group lifted their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research note on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Mizuho lifted their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Tuesday, November 19th. Truist Financial lifted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Finally, Macquarie assumed coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price on the stock. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $14.59 on Thursday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The firm has a market capitalization of $1.25 billion, a P/E ratio of -12.16, a P/E/G ratio of 1.74 and a beta of 1.57. The company’s 50 day moving average price is $14.02 and its two-hundred day moving average price is $13.25.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.